10 Paid Clinical Research Studies in Lenexa, Kansas

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

The main purpose of this study is to measure how food affects the amount of tersolisib that gets into the bloodstream. Each participant will receive two single oral doses of tersol

📍 Lenexa Clinic — Lenexa, Kansas

💵 Each participant will receive two single oral doses of tersolisib, one under fasted conditions and one with either a hig

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

The purpose of the study is to find out if NNC0721-8060 is safe and how it works in people living with overweight or obesity.

📍 ICON Early Phase Services, LLC — Lenexa, Kansas

A Study of IBI3032 in Healthy Participants

This is a randomized, double-blind, placebo-controlled Phase I clinical study evaluating the safety, tolerability, and PK of a single dose of IBI3032 in healthy participants. This

📍 ICON Clinical Research — Lenexa, Kansas

First Time in Human Study of Long Acting VH4524184 Formulations

The purpose of this study is to identify 1 or more doses of parenterally administered VH4524184 that are safe, well tolerated and yield a PK drug exposure profile necessary to deli

📍 GSK Investigational Site — Lenexa, Kansas

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

This is a Phase 1, open-label, three-part, study in approximately 96 healthy adult participants between 18 and 55 years of age (both inclusive) (16 participants in Part 1, 20 parti

📍 ICON, Clinical Research Phase I Unit — Lenexa, Kansas

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation

The purpose of this study is to compare safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of the currently marketed formulation of inclisiran with a new formul

📍 Lenexa Research Unit — Lenexa, Kansas

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.

📍 ICON Clinical Research: Lenexa — Lenexa, Kansas

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of the investigational RSV/hMPV combination vaccine and investiga

📍 GSK Investigational Site — Lenexa, Kansas

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

The purpose of this study is to assess safety, reactogenicity, and immune response of the candidate UTI vaccine compared to placebo in adults between and including 18-64 years of a

📍 GSK Investigational Site — Lenexa, Kansas

A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is still being tested in stu

📍 ICON Early Phase Services, LLC — Lenexa, Kansas

💵 In this study, participants will receive either NNC6989-0001 or a placebo; which treatment each participant receives wil